PP 03
ESTABLISHMENT OF EX VIVO DRUG SENSITIVITY SCREENING PLATFORM FOR LEUKAEMIA AND MULTIPLE MYELOMA USING A SOUTH AFRICAN PATIENT COHORT
Vanelle Kenmogne L1, Austin Malise Thudzelani Takalani1, Ekene Emmanuel Nweke1, Mutsa M Takundwa1, June Fabian2, Heather Maher2, Justin Du Toit2, Vinitha Philip-Cherian3, Pascaline Fonteh Fru1, Deepak Balaji Thimiri Govindaraj4,**
Autor para correspondência
1 Department of Surgery, University of the Witwatersrand, Johannesburg, South Africa
2 Synthetic Nanobiotechnology and Biomachines, Synthetic Biology and Precision Medicine Centre, NextGeneration Health Cluster, Council for Scientific and Industrial Research, Pretoria, South Africa
3 Wits Donald Gordon Medical Centre, Johannesburg, South Africa
4 Department of Haematology, Chris Hani Baragwanath Academic Hospital, Johannesburg South Africa
Lido
1024
Vezesque se leu este artigo
469
Total PDF
555
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 17 | 6 | 23 |
| 2025 5 | 53 | 9 | 62 |
| 2025 4 | 35 | 19 | 54 |
| 2025 3 | 43 | 12 | 55 |
| 2025 2 | 34 | 23 | 57 |
| 2025 1 | 27 | 19 | 46 |
| 2024 12 | 28 | 20 | 48 |
| 2024 11 | 35 | 22 | 57 |
| 2024 10 | 25 | 27 | 52 |
| 2024 9 | 26 | 17 | 43 |
| 2024 8 | 34 | 31 | 65 |
| 2024 7 | 20 | 23 | 43 |
| 2024 6 | 19 | 25 | 44 |
| 2024 5 | 23 | 26 | 49 |
| 2024 4 | 17 | 14 | 31 |
| 2024 3 | 21 | 25 | 46 |
| 2024 2 | 28 | 32 | 60 |
| 2024 1 | 25 | 23 | 48 |
| 2023 12 | 8 | 18 | 26 |
| 2023 11 | 19 | 35 | 54 |
| 2023 10 | 18 | 43 | 61 |
Mostrar tudo
